✦ LIBER ✦

Successful treatment of acute monocytic leukemia with intracranial hemorrhage as the first manifestation

✍ Scribed by Chihiro Kawakami; Akiko Inoue; Kimitaka Takitani; Masako Yuki; Hiroshi Tamai

Book ID: 108973002
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 297 KB
Volume: 52
Category: Article
ISSN: 1328-8067
DOI: 10.1111/j.1442-200x.2010.03138.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gingival leukemic infiltration as the fi

Gingival leukemic infiltration as the first manifestation of acute myeloid leukemia

✍ Paulo Sérgio da Silva Santos; Alexandra Fontes; Flávio de Andrade; Suzana Cantan 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 555 KB

Successful treatment of a 93-year-old pa

Successful treatment of a 93-year-old patient with hypoplastic acute monocytic leukemia using macrophage colony-stimulating factor

✍ Ayako Watanabe; Yasunori Kawachi; Yukihiro Sakamoto; Kimiko Ishikawa; Toshio Nis 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 744 KB

Granulocytic sarcoma of the prostate as

Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia

✍ F. Thalhammer; H. Gisslinger; A. Chott; O. Haas; A. Etele-Hainz; T. Helbich; R. 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 258 KB

VP 16–213 and cyclophosphamide in the tr

VP 16–213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features

✍ Hurd, David D. ;Peterson, Bruce A. ;McKenna, Robert W. ;Bloomfield, Clara D. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

## Abstract The treatment of refractory acute nonlymphocytic leukemia remains a major clinical problem in leukemia therapy. VP 16–213 is an investigational agent that may have specificity for monocytic blasts, and the combination of VP 16–213 and cyclophosphamide is synergistic in experimental leuk

Acute myelogenous leukemia as a second m

Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease

✍ Alfred A. Bartolucci; Charlene Liu; John R. Durant; Richard A. Gams 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 2 views

Gemtuzumab ozogamicin as first-line trea

Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemia

✍ Wassim McHayleh; Kenneth Foon; Robert Redner; Rajesh Sehgal; Anastasios Raptis; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views